Becton Dickinson

Becton Dickinson is a leading global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. The company was founded in 1897 by Fairleigh Dickinson and Maximilian Becton and is headquartered in Franklin Lakes, New Jersey. Becton Dickinson operates in over 50 countries worldwide, including United States, China, Japan, and Germany, and has a diverse portfolio of products that cater to various medical specialties, including Infectious Disease, Oncology, and Surgery. The company's products are used in hospitals, clinics, and laboratories, and are also sold to Pharmaceutical and Biotechnology companies, such as Pfizer, Merck & Co., and Amgen.

● History

Becton Dickinson has a rich history that spans over 120 years, with its roots dating back to 1897 when Fairleigh Dickinson and Maximilian Becton founded the company in New York City. The company's early products included Hypodermic Needles and Syringes, which were designed to improve the safety and efficacy of medical injections. Over the years, the company has expanded its product portfolio through strategic acquisitions, including the purchase of Deseret Medical, SpectraMed, and TriPath Imaging. Becton Dickinson has also collaborated with other companies, such as Johnson & Johnson, Medtronic, and Roche Holding, to develop new products and technologies. The company has received numerous awards and recognition, including the National Medal of Technology, the Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring, and the Shingo Prize for Operational Excellence.

● Products

Becton Dickinson offers a wide range of medical devices, instrument systems, and reagents that cater to various medical specialties, including Infectious Disease, Oncology, and Surgery. The company's product portfolio includes Biosafety Cabinets, Cell Sorters, Flow Cytometers, and Microscopy Systems, which are designed to improve the safety and efficacy of medical research and diagnosis. Becton Dickinson's products are used in hospitals, clinics, and laboratories, and are also sold to Pharmaceutical and Biotechnology companies, such as Pfizer, Merck & Co., and Amgen. The company's products have been used in various medical applications, including Cancer Research, Gene Therapy, and Regenerative Medicine, and have been recognized by organizations such as the National Institutes of Health, the American Cancer Society, and the World Health Organization.

● Research and Development

Becton Dickinson has a strong commitment to research and development, with a focus on developing innovative products and technologies that improve the safety and efficacy of medical care. The company's research and development efforts are focused on various areas, including Infectious Disease, Oncology, and Surgery, and involve collaborations with other companies, such as Johnson & Johnson, Medtronic, and Roche Holding. Becton Dickinson has also partnered with academic institutions, such as Harvard University, Stanford University, and Massachusetts Institute of Technology, to develop new products and technologies. The company's research and development efforts have led to the development of various innovative products, including Biosensors, Microfluidics Systems, and Nanotechnology-based Diagnostics, which have been recognized by organizations such as the National Science Foundation, the American Association for the Advancement of Science, and the Institute of Electrical and Electronics Engineers.

● Acquisitions and Partnerships

Becton Dickinson has a history of strategic acquisitions and partnerships that have helped the company expand its product portfolio and improve its market position. The company has acquired several companies, including Deseret Medical, SpectraMed, and TriPath Imaging, and has partnered with other companies, such as Johnson & Johnson, Medtronic, and Roche Holding, to develop new products and technologies. Becton Dickinson has also collaborated with academic institutions, such as Harvard University, Stanford University, and Massachusetts Institute of Technology, to develop new products and technologies. The company's acquisitions and partnerships have helped it establish a strong presence in various markets, including the United States, Europe, and Asia, and have enabled it to compete with other major medical technology companies, such as Medtronic, Johnson & Johnson, and Siemens Healthineers.

● Corporate Affairs

Becton Dickinson is a publicly traded company listed on the New York Stock Exchange under the ticker symbol BDX. The company is headquartered in Franklin Lakes, New Jersey, and has operations in over 50 countries worldwide, including United States, China, Japan, and Germany. Becton Dickinson is led by a team of experienced executives, including Tom Polen, the company's president and chief executive officer, and David Hickey, the company's chief financial officer. The company has a strong commitment to corporate social responsibility, with a focus on improving the safety and efficacy of medical care, reducing its environmental impact, and promoting diversity and inclusion in the workplace. Becton Dickinson has been recognized by organizations such as the Dow Jones Sustainability Index, the FTSE4Good Index, and the Human Rights Campaign Foundation for its corporate social responsibility efforts. Category:Medical technology companies